CA990647A - Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use - Google Patents

Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use

Info

Publication number
CA990647A
CA990647A CA165,838A CA165838A CA990647A CA 990647 A CA990647 A CA 990647A CA 165838 A CA165838 A CA 165838A CA 990647 A CA990647 A CA 990647A
Authority
CA
Canada
Prior art keywords
production
pharmaceutical compositions
serum globulin
intravenously injectable
modified serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA165,838A
Other languages
English (en)
Other versions
CA165838S (en
Inventor
Duane D. Schroeder
John L. Lundblad
Albert R. Pappenhagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Application granted granted Critical
Publication of CA990647A publication Critical patent/CA990647A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA165,838A 1972-03-13 1973-03-12 Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use Expired CA990647A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23400672A 1972-03-13 1972-03-13

Publications (1)

Publication Number Publication Date
CA990647A true CA990647A (en) 1976-06-08

Family

ID=22879492

Family Applications (1)

Application Number Title Priority Date Filing Date
CA165,838A Expired CA990647A (en) 1972-03-13 1973-03-12 Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use

Country Status (6)

Country Link
JP (1) JPS5538931B2 (cg-RX-API-DMAC7.html)
AT (1) AT321466B (cg-RX-API-DMAC7.html)
CA (1) CA990647A (cg-RX-API-DMAC7.html)
DE (1) DE2311333C2 (cg-RX-API-DMAC7.html)
ES (1) ES412551A1 (cg-RX-API-DMAC7.html)
FR (1) FR2183679A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2008213A1 (en) * 1989-02-21 1990-08-21 David A. Hilborn Method of fragmenting certain monoclonal antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792555C3 (de) * 1968-09-19 1980-01-10 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung

Also Published As

Publication number Publication date
JPS5538931B2 (cg-RX-API-DMAC7.html) 1980-10-07
FR2183679B1 (cg-RX-API-DMAC7.html) 1976-05-14
FR2183679A1 (en) 1973-12-21
DE2311333C2 (de) 1982-10-21
JPS48103723A (cg-RX-API-DMAC7.html) 1973-12-26
DE2311333A1 (de) 1973-09-27
AT321466B (de) 1975-04-10
ES412551A1 (es) 1976-01-16

Similar Documents

Publication Publication Date Title
AU462239B2 (en) New phenyl-imidazolyl-alkanyl derivatives, their production and their pharmaceutical use
AU482733B2 (en) Pharmaceutical compositions
AU471813B2 (en) Pharmaceutical compositions and process fob manufacture
CA1000713A (en) Aminophenylamidines, their production and their pharmaceutical use
IL44779A0 (en) Chemically modified polypeptide antigens,their production and pharmaceutical compositions containing them
CA974170A (en) Pharmaceutical compositions
CA943128A (en) Penicillins, their preparation and their pharmaceutical use
CA944692A (en) Pharmaceutical composition and process for the preparation thereof
CA990647A (en) Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
AU3017971A (en) Pharmaceutical composition
AU476623B2 (en) 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof
AU476390B2 (en) Pharmaceutical composition
IL37234A0 (en) Thiazole derivatives,their manufacture and pharmaceutical compositions containing them
AU461136B2 (en) Pharmaceutical composition
PH9370A (en) 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof
AU3041671A (en) Pharmaceutical preparation
CA911883A (en) Lyophilized erythrocyte composition
CA859701A (en) Pharmaceutical composition and process for the manufacture thereof
CA859700A (en) Pharmaceutical preparation and process for the manufacture thereof
CA884857A (en) Pharmaceutical composition
CA885421A (en) Pharmaceutical composition
CA851190A (en) Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions
AU454679B2 (en) Lyophilized erythrocyte composition
CA840975A (en) Pharmaceutical composition
CA840974A (en) Pharmaceutical composition